Biovet JSC (LTS:0III) Accounts Payable: лв161.89 Mil (As of Dec. 2016)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biovet JSC Accounts Payable?

Biovet JSC LTS:0III Accounts Payable is лв161.89 Mil as of Dec. 2016. The stock has 1 warning sign investors should review.

Biovet JSC's Accounts Payable for the quarter that ended in Dec. 2016 was лв161.89 Mil.

Biovet JSC's quarterly Accounts Payable declined from Jun. 2016 (лв37.13 Mil) to Sep. 2016 (лв33.98 Mil) but then increased from Sep. 2016 (лв33.98 Mil) to Dec. 2016 (лв161.89 Mil).

Biovet JSC's annual Accounts Payable increased from Dec. 2014 (лв90.40 Mil) to Dec. 2015 (лв114.57 Mil) and increased from Dec. 2015 (лв114.57 Mil) to Dec. 2016 (лв161.89 Mil).

Biovet JSC Accounts Payable Historical Data

* Premium members only.

The historical data trend for Biovet JSC's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biovet JSC Accounts Payable Chart

Biovet JSC Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Accounts Payable
Get a 7-Day Free Trial 76.68 87.66 90.40 114.57 161.89

Biovet JSC Quarterly Data
Dec09 Dec10 Dec11 Dec12 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 114.57 34.04 37.13 33.98 161.89

Biovet JSC Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of лв161.89 Mil mean?
Biovet JSC (LTS:0III) has a Accounts Payable of лв161.89 Mil as of Dec. 2016. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Biovet JSC and its competitors.
Is Biovet JSC's Accounts Payable too high?
Biovet JSC's current Accounts Payable is лв161.89 Mil.
How does Biovet JSC's Accounts Payable compare to ADMP and AGRX?
Biovet JSC's Accounts Payable of лв161.89 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Biovet JSC and its competitors. Biovet JSC's current Accounts Payable is лв161.89 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biovet JSC stock overvalued right now?
Biovet JSC (LTS:0III) has a current Accounts Payable of лв161.89 Mil. The current Accounts Payable is лв161.89 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Biovet JSC (LTS:0III), the current Accounts Payable is лв161.89 Mil as of Dec. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biovet JSC Business Description

Biovet JSC manufactures & markets medicated and nutritional feed additives, enzymes, bulk active substances & pharmaceuticals for animal productivity & health. It offers intermediates, active ingredients and medicines for human pharmaceutical industry.